MedTrace Logo

Effectiveness of Digital Capacitive Diathermy Versus Ultrasound on Myofascial Trigger Points

NCT03154632 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2018-05-03

No results posted yet for this study

Summary

The main objective:

To compare the effect on muscle tone between the application of digital capacitive diathermy and the application of ultrasound on the myofascial trigger points (MTP) of the upper trapezius muscle.

Hypothesis:

The application of digital capacitive diathermy on myofascial trigger points of the trapezius muscle compared to the application of ultrasound produces objective changes in muscle tone, and this change is superior to the changes generated by the US.

Conditions

  • Muscle Tonus

Interventions

DEVICE

Ultrasound Therapy

Ultrasound equipment will be used, choosing a continuous mode, with a frequency of 1MHz and an intensity of 1.0 W/cm2. The technique will be applied during 6 minutes with circular movements and a speed of approximately between 2.5 and 4 centimeters per second.

DEVICE

Digital Capacitive Diathermy Therapy

The DCD equipment will be used choosing the "musculotendinous injury FAST" program which lasts 6 minutes. The applicator will move with a velocity approximately between 2.5 and 4 centimeters per second.

Sponsors & Collaborators

  • Universidad San Jorge

    lead OTHER

Principal Investigators

  • Carolina Jiménez-Sánchez, MSc · Universidad San Jorge

  • Maria Ortiz-Lucas, PhD · Universidad San Jorge

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-10-01
Completion
2017-10-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03154632 on ClinicalTrials.gov